Sørensen M, Mueller T C, Lefèvre J P. "Method for the Synthesis of Letermovir impurity 111" [P]. European Patent, EP 3844470 A1, 2022-06-28.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 来特莫韦杂质111 in Pharmaceutical Formulations". Anal. Chim. Acta, 2025, 1416, (12), 6722-6741.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来特莫韦杂质111 as an Impurity". J. Chromatogr. A, 2013, 1590, 1567-1579.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Letermovir impurity 111 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2012, 577, 9798-9815.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 来特莫韦杂质111 Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2014, 1402, (6), 984-1000.